Eli Lilly and Company and Incyte announced results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily...
Read more
Novavax, Inc. , a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the initiation of crossover arms in...
Read more
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced its participation in a newly expanded investigator-initiated...
Read more
Cerecor Inc., a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and...
Read more
Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it has decided to review its...
Read more
Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced preliminary data from its Phase 1 study...
Read more
Thermo Fisher Scientific has expanded its pharma services footprint with two new state-of-the-art facilities in Rheinfelden and Weil am Rhein,...
Read more
Thousands of volunteers are flocking to research hospitals across Pakistan to join final-stage clinical trials of a Chinese-made vaccine for...
Read more
The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here on Thursday with...
Read morePfizer Inc. announced that the first participant has been dosed in the Phase 3 BASIS study of marstacimab (PF-06741086), an...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
